A Placebo-Controlled, Two-Part Study, Oral Dose to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of CNTX-6970 in Healthy Subjects
Clinical trial NCT03787004 · COMPLETED
Trial details
- NCT number
- NCT03787004
- Sponsor
- Centrexion Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-14
- Primary completion
- 2018-08-19
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.